GeneOne Life Science Valuation
Is A011000 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of A011000 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate A011000's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate A011000's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for A011000?
Other financial metrics that can be useful for relative valuation.
What is A011000's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | ₩190.39b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 5x |
Enterprise Value/EBITDA | -7.2x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does A011000's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 23.6x | ||
A182400 NKMAX | 16.5x | n/a | ₩172.7b |
A217330 Cytogen | 46.6x | n/a | ₩165.6b |
A065660 Anterogen.Co.Ltd | 21.9x | n/a | ₩146.0b |
A138610 NIBEC | 9.6x | n/a | ₩185.7b |
A011000 GeneOne Life Science | 4.7x | n/a | ₩190.4b |
Price-To-Sales vs Peers: A011000 is good value based on its Price-To-Sales Ratio (4.7x) compared to the peer average (23.6x).
Price to Earnings Ratio vs Industry
How does A011000's PE Ratio compare vs other companies in the KR Biotechs Industry?
Price-To-Sales vs Industry: A011000 is good value based on its Price-To-Sales Ratio (4.7x) compared to the KR Biotechs industry average (9.6x).
Price to Sales Ratio vs Fair Ratio
What is A011000's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 4.7x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate A011000's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.